LESLIE PHELPS: Open Payments
NPI 1598005654 · CORBIN, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,074 in 16 payments from 9 companies in 2025. Trend: 2023 $594 · 2024 $262 · 2025 $4,074
Speaker / faculty: $3,813Food & beverage: $260
| Company | Payments | Amount |
|---|---|---|
| Optos, Inc. | 1 | $3,813 |
| ABBVIE INC. | 4 | $66 |
| Otsuka America Pharmaceutical, Inc. | 3 | $59 |
| Teva Pharmaceuticals USA, Inc. | 2 | $38 |
| Alkermes, Inc. | 2 | $31 |
| AstraZeneca Pharmaceuticals LP | 1 | $18 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $17 |
| Axsome Therapeutics, Inc. | 1 | $17 |
| Indivior Inc. | 1 | $14 |
Products named: REXULTI, MAVYRET, AUSTEDO XR, LYBALVI, CAPLYTA, Auvelity, QULIPTA, SUBLOCADE.
Industry payments across KY — which companies pay providers there.
